Rocket Pharmaceuticals Inc (RCKT)’s Ratio Roundup: Key Metrics for Trailing Twelve Months

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Rocket Pharmaceuticals Inc’s stock clocked out at $14.10, down -0.07% from its previous closing price of $14.11. In other words, the price has decreased by -$0.07 from its previous closing price. On the day, 1.21 million shares were traded. RCKT stock price reached its highest trading level at $15.01 during the session, while it also had its lowest trading level at $14.05.

Ratios:

To gain a deeper understanding of RCKT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.05 and its Current Ratio is at 6.05. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.

On April 02, 2024, Goldman started tracking the stock assigning a Neutral rating and target price of $39.

On October 24, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $65.Cantor Fitzgerald initiated its Overweight rating on October 24, 2023, with a $65 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 21 ’24 when Militello John sold 1,224 shares for $13.05 per share. The transaction valued at 15,978 led to the insider holds 49,310 shares of the business.

Patel Kinnari sold 4,588 shares of RCKT for $59,892 on Nov 21 ’24. The insider now owns 392,395 shares after completing the transaction at $13.05 per share. On Nov 21 ’24, another insider, Shah Gaurav, who serves as the CEO of the company, sold 11,091 shares for $13.05 each. As a result, the insider received 144,782 and left with 707,328 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 1285315200 and an Enterprise Value of 1076206464.

Stock Price History:

Over the past 52 weeks, RCKT has reached a high of $32.53, while it has fallen to a 52-week low of $12.62. The 50-Day Moving Average of the stock is -17.26%, while the 200-Day Moving Average is calculated to be -35.14%.

Shares Statistics:

It appears that RCKT traded 907.07K shares on average per day over the past three months and 1196590 shares per day over the past ten days. A total of 90.28M shares are outstanding, with a floating share count of 83.00M. Insiders hold about 8.95% of the company’s shares, while institutions hold 98.34% stake in the company. Shares short for RCKT as of 1730332800 were 11897507 with a Short Ratio of 13.12, compared to 1727654400 on 11403110. Therefore, it implies a Short% of Shares Outstanding of 11897507 and a Short% of Float of 27.67.

Most Popular